Prophase Labs Inc Quick Ratio (PRPH) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Prophase Labs Inc   (PRPH)

Prophase Labs Inc 's Quick Ratio

PRPH's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0 a new company low.

Within Major Pharmaceutical Preparations industry 511 other companies have achieved higher Quick Ratio than Prophase Labs Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 5271 to 5522.

Explain Quick Ratio?
How much Cash & cash equivalents PRPH´s has?
What are PRPH´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PRPH Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change 126.67 % 133.28 % 83.5 % 92.65 % -8.52 %
Y / Y Cash & cash equivalent Change -88.3 % -64.77 % -97.63 % -19.48 % -90.4 %
Quick Ratio MRQ 0 0 0 0.01 0.01
PRPH's Total Ranking # 5522 # 5271 # 5378 # 5476 # 4735
Seq. Current Liabilities Change 3.53 % 5.7 % -3.99 % 115.75 % 6.54 %
Seq. Cash & cash equivalent Change -35.48 % -65.56 % -77.78 % 136.84 % 94.32 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 512
Healthcare Sector # 1049
Overall Market # 5398


Quick Ratio Statistics
High Average Low
11.8 2.09 0
(Mar 31 2018)   (Jun 30 2026)




Financial Statements
Prophase Labs Inc 's Current Liabilities $ 58 Millions Visit PRPH's Balance sheet
Prophase Labs Inc 's Cash & cash equivalent $ 0 Millions Visit PRPH's Balance sheet
Source of PRPH's Sales Visit PRPH's Sales by Geography


Cumulative Prophase Labs Inc 's Quick Ratio

PRPH's Quick Ratio for the trailling 12 Months

PRPH Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 107.42 % 73.31 % 44.28 % 31.09 % 19.44 %
Y / Y Cash & cash equivalent TTM Growth -88.04 % -88.72 % -89.7 % -45.85 % -58.55 %
Quick Ratio TTM 0 0 0 0.03 0.04
Total Ranking TTM # 4726 # 3554 # 3565 # 3486 # 4030
Seq. Current Liabilities TTM Growth 17.08 % 20.28 % 18.04 % 24.78 % -2.18 %
Seq. Cash & cash equivalent TTM Growth -21.66 % -7.56 % -83.13 % -2.15 % -26.06 %

Quick ratio ranking by company, industry and sector >> Back to PRPH Financial Strength Comparisons >> Go to Compare PRPH Quick Ratio to its Competitors

On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q2 2026 to $58.09 millions, cumulative Quick Ratio